DE1695167A1 - Verfahren zur Herstellung von Benzodiazepin-Derivaten - Google Patents
Verfahren zur Herstellung von Benzodiazepin-DerivatenInfo
- Publication number
- DE1695167A1 DE1695167A1 DE19661695167 DE1695167A DE1695167A1 DE 1695167 A1 DE1695167 A1 DE 1695167A1 DE 19661695167 DE19661695167 DE 19661695167 DE 1695167 A DE1695167 A DE 1695167A DE 1695167 A1 DE1695167 A1 DE 1695167A1
- Authority
- DE
- Germany
- Prior art keywords
- hydrogen
- lower alkyl
- halogen
- formula
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 10
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title claims description 3
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 title claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- JINBYESILADKFW-UHFFFAOYSA-N aminomalonic acid Chemical compound OC(=O)C(N)C(O)=O JINBYESILADKFW-UHFFFAOYSA-N 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- 150000001412 amines Chemical group 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- TXYXDDZSYUFTDJ-UHFFFAOYSA-N 2-(dipropylamino)propanedioic acid Chemical compound CCCN(CCC)C(C(O)=O)C(O)=O TXYXDDZSYUFTDJ-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- WLTCKEHCTUYJGI-UHFFFAOYSA-N Diethyl aminomalonate Chemical compound CCOC(=O)C(N)C(=O)OCC WLTCKEHCTUYJGI-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical group [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- GLFVNTDRBTZJIY-UHFFFAOYSA-N diethyl 2-aminopropanedioate;hydron;chloride Chemical compound Cl.CCOC(=O)C(N)C(=O)OCC GLFVNTDRBTZJIY-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51278365A | 1965-12-09 | 1965-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1695167A1 true DE1695167A1 (de) | 1970-12-10 |
Family
ID=24040543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661695167 Pending DE1695167A1 (de) | 1965-12-09 | 1966-11-24 | Verfahren zur Herstellung von Benzodiazepin-Derivaten |
Country Status (11)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1269906B (de) * | 1957-06-14 | 1968-06-06 | Alle Heida | Eckenausbildung fuer Fahrzeugkarosserien |
| DE2600202A1 (de) * | 1975-01-06 | 1976-07-15 | Clin Midy | Verfahren zur herstellung von benzdiazepinderivaten |
-
1966
- 1966-11-16 IL IL2686866A patent/IL26868A/xx unknown
- 1966-11-21 CH CH1667366A patent/CH484164A/de not_active IP Right Cessation
- 1966-11-24 DE DE19661695167 patent/DE1695167A1/de active Pending
- 1966-11-28 BE BE690314D patent/BE690314A/xx unknown
- 1966-12-02 SE SE16541/66A patent/SE312559B/xx unknown
- 1966-12-02 BR BR18504866A patent/BR6685048D0/pt unknown
- 1966-12-06 NL NL6617121A patent/NL6617121A/xx unknown
- 1966-12-07 FR FR86405A patent/FR1503347A/fr not_active Expired
- 1966-12-07 ES ES334300A patent/ES334300A1/es not_active Expired
- 1966-12-08 GB GB5495666A patent/GB1116918A/en not_active Expired
-
1969
- 1969-12-31 MY MY6900124A patent/MY6900124A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1269906B (de) * | 1957-06-14 | 1968-06-06 | Alle Heida | Eckenausbildung fuer Fahrzeugkarosserien |
| DE2600202A1 (de) * | 1975-01-06 | 1976-07-15 | Clin Midy | Verfahren zur herstellung von benzdiazepinderivaten |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1116918A (en) | 1968-06-12 |
| BE690314A (enrdf_load_stackoverflow) | 1967-05-29 |
| NL6617121A (enrdf_load_stackoverflow) | 1967-06-12 |
| FR1503347A (fr) | 1967-11-24 |
| ES334300A1 (es) | 1968-02-01 |
| BR6685048D0 (pt) | 1973-12-18 |
| CH484164A (de) | 1970-01-15 |
| MY6900124A (en) | 1969-12-31 |
| IL26868A (en) | 1970-10-30 |
| SE312559B (enrdf_load_stackoverflow) | 1969-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1545934A1 (de) | Verfahren zur Herstellung von Benzodiazepin-Derivaten | |
| DE2712791A1 (de) | 10,11-dihydrobenzo eckige klammer auf 4,5 eckige klammer zu cyclohepta eckige klammer auf 1,2-b eckige klammer zu pyrazolo eckige klammer auf 4,3-e eckige klammer zu- pyridin-5 (1h) on-derivate, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE2141616C3 (de) | Oxazole- und Oxazine eckige Klammer auf 3,2-c eckige Klammer zu chinazolinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE1695167A1 (de) | Verfahren zur Herstellung von Benzodiazepin-Derivaten | |
| CH622518A5 (en) | Process for the preparation of novel ergoline compounds | |
| AT263787B (de) | Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten und Säureadditionssalzen davon | |
| DE1812231C3 (de) | Verfahren zur Herstellung von 3-Alkyl- 5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-onderivaten | |
| CH617197A5 (enrdf_load_stackoverflow) | ||
| DE2010884C2 (de) | In 4-Stellung durch einen sauerstoffhaltigen Rest substituierte 8-Chlor-6-phenyl-4H-s-triazolo-[4,3-a] [1,4]-benzodiazepine und Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel | |
| DE1908496A1 (de) | Neue Thiophenderivate und Verfahren zu ihrer Herstellung | |
| DE2248959A1 (de) | Indolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| DE1793693A1 (de) | Verfahren zur Herstellung von Adamantanverbindungen | |
| DE2417917A1 (de) | Verfahren zur herstellung von indolderivaten mit ankondensiertem ringsystem | |
| DE2042758A1 (de) | Verfahren zur Herstellung von Benzodiazepinderivaten | |
| US2750390A (en) | Nicotinic acid ester | |
| AT256114B (de) | Verfahren zur Herstellung von neuen Benzodiazepinderivaten | |
| AT327208B (de) | Verfahren zur herstellung von neuen benzodiazepinderivaten und deren saureadditionssalzen | |
| DE19830556A1 (de) | Verfahren zur Herstellung von Carbonyldiimidazolen | |
| DE3150918C1 (de) | Verfahren zur Herstellung von Aniliden in der Ergolinreihe | |
| AT240373B (de) | Verfahren zur Herstellung von Benzodiazepin-Derivaten | |
| DE2625029A1 (de) | Verfahren zur herstellung von 3-phenylindol-2-carbonsaeurenitrilen | |
| DE1931870A1 (de) | Verfahren zur Herstellung von Benzodiazepinderivaten | |
| AT302324B (de) | Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten sowie von Salzen dieser Verbindungen | |
| DE2019719C3 (de) | 1,3,4-Substituierte 5-Dimethylaminouracile und Verfahren zu ihrer Herstellung | |
| AT395154B (de) | Verfahren zur herstellung von neuen imidazo(1,5-a)(1,4)diazepinverbindungen |